1. 1488PVemurafenib in patients (pts) harboring BRAF V600 mutation: Results of non-small cell lung cancer (NSCLC) cohort from the AcSé trial. (23rd October 2018) Authors: Mazières, J; Montané, L; Barlesi, F; Quantin, X; Trédaniel, J; Le Treut, J; Avrillon, V; Lavolé, A; Westeel, V; Orsini Piocelle, F; Pichon, E; Thiberville, L; Borel, C; Renault, P A; Jaffro, M; Collot, S; Ferretti, G; Legrand, F; Mahier Ait Oukhatar, C; Blay, J Y Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 182TiPEXPRESS study: A multicenter, prospective trial in progress exploring the association between low level of genomic alteration and exceptional and unexpected response to targeted therapies in patients with solid tumors. (23rd October 2018) Authors: Italiano, A; Le Saux, O; André, F; Filleron, T; Spaeth, D; Heudel, P-E; Albiges, L; Bachelot, T; Gonçalves, A; Pierga, J-Y; Barlesi, F; Boige, V; Lebbe, C; Mortier, L; Frenel, J-S; Tredan, O; Jimenez, M; Legrand, F; Ferté, C Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 63PEXPRESS study: A multicenter, prospective trial in progress exploring the association between low level of genomic alteration and exceptional and unexpected response to targeted therapies in patients with solid tumors. (5th March 2018) Authors: Le Saux, O; Italiano, A; Spaeth, D; Heudel, P-E; Filleron, T; Pezzella, V; Jimenez, M; Legrand, F; Ferté, C Journal: Annals of oncology Issue: Volume 29(2018)Supplement 3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗